Objective To characterize actual achieved patterns of oxygenation in infants born appropriate vs small for gestational age (SGA) randomized to a lower (85-89%) vs higher (91%-95%) oxygen saturation target in the Surfactant Positive Pressure and Oxygen Trial. To determine the association between achieved oxygen saturation levels and survival in infants born appropriate vs SGA enrolled in the Surfactant Positive Pressure and Oxygen Trial.
Trial registration ClinicalTrials.gov: NCT00233324.
See editorial, p 9 C ontroversy persists regarding the optimal oxygen saturation range in preterm infants. A series of large, collaborative, multicenter trials that randomized preterm infants (<28 weeks of gestation) to a lower (85%-89%) vs higher (91%-95%) oxygen saturation target, documented a decrease in the incidence of severe retinopathy of prematurity with an unexpected increase in mortality in the lower target group. 1, 2 Owing to these emerging data, some clinicians are avoiding an oxygen saturation target of 85%-89%, even though the reason for the increase in mortality is currently unknown.
We and others 3, 4 have shown an association between an increased incidence of intermittent hypoxemia during early postnatal life and morbidity. In addition, we have shown a higher number of intermittent hypoxemia events in a subcohort of infants enrolled in the Surfactant Positive Pressure and Oxygen Trial (SUPPORT) 1 who were randomized to the lower vs higher oxygen saturation target. 5 Furthermore, in the entire SUPPORT infant cohort, we have shown most recently that infants born small for gestational age (SGA) had a higher mortality than infants born appropriate for gestational age (AGA), with the highest mortality seen in the infants who were SGA randomized to the lower oxygen saturation target. 6 Therefore, being SGA, having a lower oxygen saturation level, and a high incidence of AGA Appropriate for gestational age COT Canadian Oxygen Trial HR Hazard ratio SGA Small for gestational age SUPPORT Surfactant Positive Pressure and Oxygen Trial intermittent hypoxemia events may be a synergistic combination that increases the risk of death in extremely preterm infants. Previous analyses of SUPPORT data were conducted by an intention-to-treat analysis. However, the challenge of keeping the infants within each target resulted in overlap of median oxygen saturation levels between the lower and higher target groups. Therefore, the purpose of this study was 2-fold: to characterize actual achieved patterns of oxygenation in infants who were AGA vs SGA enrolled in SUPPORT and randomized to a higher vs lower oxygen saturation target and the association between actual achieved oxygen saturation levels during the first 72 hours of life and survival in infants who were AGA and SGA.
Methods
This study included 1316 infants born preterm (24 0/7 -27 6/7 weeks of gestation) who were enrolled in SUPPORT, 1 a randomized trial (ClinicalTrials.gov: NCT00233324) to compare the target ranges of 85%-89% (lower) or 91%-95% (higher) oxygen saturation on the composite outcome of severe retinopathy of prematurity, death before hospital discharge, or both. In the main trial, 654 infants were randomized to the lower target while 662 infants were randomized to the higher target. Of the 654 infants in the lower target group, 41 were born SGA and of the 662 infants in the higher target, 55 were SGA. SGA was defined as <10% on the Alexander curves. 7 Gestational age was based on last menstrual period, obstetrical variables, and prenatal ultrasound examination and/or physical criteria, neurologic examination, combined physical and gestational age examination, or examination of the lens. Infants were randomized by 2 hours after birth to the specified target until 36 weeks of postmenstrual age or until the infant no longer required supplemental oxygen and ventilator or continuous positive airway pressure for >72 hours, whichever came first. During this period, oxygen saturation data were sampled continuously every 10 seconds (0.1 Hz) with an oximeter averaging time of 16 seconds (Masimo, Radical, Yorba, California) . At 2 sites, higher resolution data were collected in 128 infants with 1 sample every 2 seconds (0.5 Hz) and an averaging time of 2 seconds. Data from these 2 sites were downsampled to 1 sample every 10 seconds to allow for similar sampling resolution among sites. Institutional review board approval and parental consent was obtained for the main SUPPORT trial with additional institutional review board approval for the current study.
Oxygen saturation waveform patterns were quantified using previously validated custom software (Matlab, Natick, Massachusetts). 8 Waveform files were screened initially for data integrity, including missing data, valid dates, and spurious noise artifact. Noise artifact included flat line of signals and values of zero for either heart rate or oxygen saturation. Infants with valid oxygen saturation data who survived until 3 days of age were included in this study. There were 1054 infants with oxygen saturation data of acceptable integrity for analysis (58 infants died and 204 infants had unacceptable quality or missing data within the first 3 days of life). For infants who died, the last day before death was removed to avoid bias in oxygen saturation patterns owing to deterioration in that interval.
During the main trial, infants were placed on electronically modified oximeters to maintain blinding of the oxygen saturation target randomization. The oximeters were altered to display 88%-92% when infants were in the randomized target but were offset by ±3% in this range and returned to true values <84% and >96%. Altered oxygen saturation readings were adjusted back to the actual original oxygen saturation values. As described, quadratic interpolation was used to estimate the distribution in transition areas where there was a lack of 1-to-1 matching. 9 Oxygen saturation data were sampled at 0.1 Hz, or 1 sample every 10 seconds. Based on the Nyquist sampling theorem, detection of intermittent hypoxemia events was limited to events ≥20 seconds in duration (2 × the sample period). Intermittent hypoxemia events were thus defined as a fall in oxygen saturation <80% for ≥20 seconds and ≤5 minutes in duration to distinguish intermittent hypoxemia events from sustained hypoxemia. Previous findings in infants enrolled in the Canadian Oxygen Trial (COT) 4 have shown a relationship between intermittent hypoxemia events and morbidity that was limited to events of >1 minute in duration. Therefore, separate analyses were performed for "shorter" intermittent hypoxemia of 20 seconds to 1 minute and "longer" intermittent hypoxemia of 1-5 minutes in duration. Median oxygen saturation and intermittent hypoxemia patterns were summarized over daily intervals.
Statistical Analyses
Daily achieved oxygen saturation patterns were displayed graphically across the first month of life among infants born SGA and AGA within each oxygen saturation target group (Figure 1) . However, comparison of achieved oxygen saturation between infants born SGA and AGA within each randomization target group was limited to the first 3 days of life, while >90% of infants were still alive, to avoid the potential bias owing to the decrease in survival resulting from an increased and disproportionate incidence of early death in the SGA group relative to the AGA group. During the first 3 days of life, comparisons were made between groups using a generalized linear model (GLIMMIX procedure) to account for correlation within multiple births.
We then sought to assess the association between oxygen saturation and growth status at birth on the outcome of death within 90 days after birth. All infants in both target groups were combined, and actual achieved oxygenation patterns were then stratified by SGA/AGA and quartiles. The bottom quartile of achieved median oxygen saturation was compared with the combined upper 3 quartiles, and the top quartile for percent time with hypoxemia (<80%) and intermittent hypoxemia was compared with the combined lower 3 quartiles. Demographic and clinical factors potentially associated with 90-day survival were determined using both Kaplan-Meier method and the Cox proportional hazard model ( Table I) . The association of the first 3-day achieved oxygenation patterns on 90-day survival between infants born SGA and AGA was evaluated using survival analysis. Probability of 90-day survival and THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 186 survival curves by SGA/AGA and each saturation variable category were explored using the Kaplan-Meier method and relative hazard ratios (HRs) of early death were calculated using Cox proportional hazard models. Infants from multiple births were included in this study with correlation within multiple births being considered in the generalized linear mixed model (GLIMMIX procedure; SAS Institute, Cary, North Carolina) and Cox proportional hazard models. All data analyses were performed using SAS version 9.4 (SAS Institute) with a 2-sided P value of .05 considered significant.
Results

Infants were enrolled from February 2005 to February 2009.
A lower 90-day survival rate was associated with lower birthweight (P < .0001) and younger gestational age (P < .0001; Table I ).
Association of SGA vs AGA Status and Oxygenation Patterns in the Higher and Lower Oxygen Saturation Target Groups
Our previous study revealed the highest mortality in infants born SGA randomized to the lower oxygen saturation target based on intention to treat design. 6 Because of the large overlap in true oxygen saturation levels between target groups, we sought to examine actual achieved patterns of oxygenation in AGA and infants born SGA in the lower and higher target groups during the first 3 days of life. (Extended daily alterations in oxygen saturation patterns and dropout rates over the first 28 days of life are presented in Figure 1 ).
Median Oxygen Saturation. Infants born AGA in the higher target had the highest median oxygen saturation compared with infants born both SGA and AGA in the lower target (both P < .0001) and infants born SGA in the higher target (P = .012) during the first 3 days of life (Table II) . In contrast, infants born SGA in the lower target maintained a significantly lower median oxygen saturation compared with all other infant groups (all P < .0001). The difference between the higher and lower target was significantly larger in the infants born SGA vs infants born AGA (2.8% vs 1.6%; P interaction = .02).
Time with Hypoxemia. During the first 3 days of life, there was no difference in the time spent with hypoxemia (<80%) between infants born AGA and infants born SGA in the higher target group (Table II) . In contrast, infants born AGA and infants born SGA in the lower target group spent a significantly greater percent of time with hypoxemia compared with infants born both AGA and SGA in the higher oxygen saturation target group (Table II) . Infants born SGA in the lower target group had the greatest amount of time with hypoxemia (4.6 ± 0.5%) compared to all infants groups, including infants born AGA within the same oxygen saturation target group (P = .0038; Table II) . The difference in time with hypoxemia between the high and low target was comparable in the infants born SGA vs infants born AGA (2.4 vs 1.3%; P interaction = 0.11; Table II ).
Intermittent Hypoxemia. Separate analyses were performed for "shorter" intermittent hypoxemia episodes (20 seconds to 1 minute) and "longer" intermittent hypoxemia episodes (1-5 minutes; Table II ). There were no differences in the incidence of shorter or longer intermittent hypoxemia between infants born SGA and infants born AGA within the higher target group. Infants born AGA in the lower target group had a greater incidence of both shorter and longer intermittent hypoxemia events compared with infants born AGA in the higher target during the first 3 days of life (both P < .0001; Table II ).
The infants born SGA and in the lower target group had the greatest incidence of longer intermittent hypoxemia events compared with all other infant groups (all P < .0001). However, there was no difference in the incidence of shorter intermittent hypoxemia events between infants born SGA and infants born AGA in the lower target group. The difference between the high and low target was significantly greater in the infants born SGA vs infants born AGA for longer intermittent hypoxemia events (9.9 vs 4.4 intermittent hypoxemia events per day; interaction P = .006) with no difference in shorter intermittent hypoxemia events (7.5 vs 5.2 intermittent hypoxemia events per day; interaction P = .34).
Association of Oxygenation Patterns with Survival in Infants
Born SGA vs Infants Born AGA Based on the above analysis, we hypothesized that nonsurvival would be associated with being SGA, having a lower median oxygen saturation, and having a higher incidence of longer intermittent hypoxemia events. Kaplan-Meier survival curves based on oxygen saturation variables are presented in Figure 2 . Median Oxygen Saturation. Median oxygen saturation was calculated for all infants then divided into quartiles. The lowest quartile for oxygen saturation (≤92%) was compared with the combined additional 3 quartiles (>92%) and stratified by SGA/ AGA (Figure 2, A) . Infants born AGA with a median oxygen saturation of >92% had the highest 90-day survival rate (90.8%) with no difference in survival between infants born SGA and infants born AGA in this oxygen saturation range (HR, 1.8; 95% CI, .8-4.;, P = .1291; Table III ). In contrast, there was a lower 90-day survival in infants born AGA (HR, 1.9; 95% CI, 1.2-2.8; P = .0013) and infants born SGA (HR, 6.1; 95% CI, 3.5-10.4; P < .0001) in the lowest quartile (≤92%) when compared with infants born AGA and in the remaining 3 quartiles (>92%). Although the infants born SGA and ≤92% had a lower survival (54.3%), the difference in survival status between infants born SGA and ≤92% and SGA infants >92% vs infants born AGA and ≤92% and AGA infants >92% was not different (interaction P = .2542).
Time with Hypoxemia. The HRs were calculated for quartile levels of percent time with hypoxemia. The top quartile of infants (≥3.2% time with hypoxemia) was compared with infants who spent <3.2% time with hypoxemia (Figure 2, B) . There was no association between the overall time with hypoxemia and survival in the AGA groups (HR, 0.98; 95% CI, 0.6-1.5; P = .9218, Table III ). In infant groups with the lowest amount of time with hypoxemia (<3.2% time), infants born SGA had an increased risk of death compared with infants born AGA (HR, 2.3; 95% CI, 1.3-4.3; P < .0077). Infants born SGA with ≥3.2% time with hypoxemia were at greater risk for death (HR, 3.9 [95% CI, 2.1-7.2] vs infants born AGA and <3.2% time with hypoxemia; P < .0001) with the lowest 90-day survival of 60.7% (interaction P = .2539).
Intermittent Hypoxemia. Because previous data from the COT showed a relationship between intermittent hypoxemia events and morbidity that was limited to intermittent hypoxemia events >1 minute in duration, 4 2 separate analyses were performed for shorter intermittent hypoxemia (20 seconds-1 minute; highest quartile; 14.7 events per day) and longer intermittent hypoxemia (1-5 minutes; highest quartile; 12 events per day) events (Figure 2, C and D) . A higher incidence of either longer or shorter intermittent hypoxemia events, as measured by the highest quartiles, was not associated with increased death in infants born AGA (Table III) . In contrast, the largest HRs were seen in the infants born SGA in the highest quartiles for both shorter intermittent hypoxemia (HR, 6.1; 95% CI, 3.2-11.8; P < .0001; interaction P = .0255) and longer intermittent hypoxemia (HR, 3.6; 95% CI, 2.0-6.3; P < .0001; interaction P = .1747) with the lowest survival of 47.4% in infants born SGA who had >14.7 shorter intermittent hypoxemia events per day. 
Discussion
Previous data from the SUPPORT multicenter trial randomizing infants to a lower (85%-89%) vs higher (91%-95%) saturation target revealed a higher mortality in the lower oxygen saturation target group. We have found evidence previously of an interaction between infants born SGA and lower oxygen targets associated with increased mortality based on an intention to treat analysis. 6 The objective of this analysis was to characterize actual achieved patterns of oxygenation in infants born AGA vs infants born SGA enrolled in SUPPORT and randomized to a higher vs lower oxygen saturation target and the association between actual achieved oxygen saturation levels and survival in infants born AGA and infants born SGA. This study found that infants born SGA in the lower target group had the lowest achieved oxygen saturation levels and highest incidence of longer intermittent hypoxemia during the first 3 days of life compared with infants born AGA with a lower target and both infants born SGA and infants born AGA with a higher target. In addition, we observed that being in the lowest quartile for median oxygen saturation during the first 3 days of life was associated with decreased infant survival at 90 days for both infants born AGA and infants born SGA, with infants born SGA with the lowest quartile oxygen saturation having a particularly low survival (54.3%). Furthermore, both time with hypoxemia and incidence of intermittent hypoxemia events were associated significantly with lower survival only in the infants born SGA.
The mechanisms by which achieved oxygenation seems to be compromised (2.2% lower) in infants born SGA assigned to the lower oxygen saturation target have yet to be elucidated. Possible contributors include impaired pulmonary vascular growth and/or pulmonary vasoconstriction. 10 Lamb models of intrauterine growth restriction have demonstrated postnatal suppression of the ventilatory response to acute hypoxia 11 and both structural and functional immaturity of the lungs 12 during early postnatal life. These factors may have resulted in a lower respiratory reserve in infants born SGA vs infants born AGA owing to impaired lung development, resulting in a higher probability for desaturation when alveolar PO2 is lower. Our study revealed a greater percentage of time with hypoxemia and a higher incidence of long intermittent hypoxemia events in infants born AGA in the lower vs higher targets, similar to previous data from Di Fiore et al 5 and consistent with McEvoy et al, 13 showing a relationship between O2 levels and intermittent hypoxemia in infants born preterm with chronic lung disease later in life. The increased incidence of intermittent hypoxemia events and time with hypoxemia may be due to a lower baseline alveolar PO2 in the lower target that, in a model-based analysis, has been shown to cause an early onset of desaturation.
14 The SEMs for mean oxygen saturation, time with hypoxemia, and intermittent hypoxemia events (Figure 1) were much larger in the SGA compared with infants born AGA. This may reflect a possible correlation between growth status and variability in oxygen saturation or may be a manifestation of a much larger sample size in the cohort of infants born AGA. Although it may not be surprising that the lower target was associated with an increase in intermittent hypoxemia events in both infants born SGA and infants born AGA, a higher incidence of intermittent hypoxemia events associated with decreased survival was only seen in the infants born SGA.
Following the results of the recent multicenter trials showing an increased mortality in infants randomized to the lower oxygen saturation target of 85%-89% 1,2 editorials have recommended a move toward a higher oxygen saturation target range of 90%-95%. 15, 16 Although the optimal specific range of oxygen saturations for infant survival has yet to be determined, this study has shown that a median oxygen saturation of ≤92% during the first 3 days of life may influence infant survival. The oxygen saturation quartiles in this study may simply reflect illness severity as opposed to a specific oxygen saturation range associated with survival and may be one possible explanation for differences in mortality outcomes between the SUPPORT and COT. 17 The SUPPORT enrollment protocol had no study exclusions after delivery. In contrast, COT enrollment occurred in the first 18 hours with exclusion criteria resulting in the most unstable infants being excluded from the study. We speculate that greater illness severity may have contributed to enhanced vulnerability to low achieved oxygen saturation in the SUPPORT vs COT cohorts. Given the limitation of additional potential illness severity contributors that may have played a role in survival during the first 72 hours of life, these results suggest that in infants born preterm, and especially infants born SGA, .1747
There were no differences in gestational age, race, sex, multiple births, or early sepsis between infant groups. Therefore, unadjusted HRs are presented. *Short: 20 seconds-1 minute; long: 1-5 minutes. †Versus highest median SpO2 quartile (AGA > 92%) or lowest quartile for time <80% (AGA < 3.2%), short intermittent hypoxemia (AGA < 14.7/d) and long intermittent hypoxemia (AGA < 12/d).
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Volume 186 survival may be improved by targeting the upper range of this oxygen saturation target during the first few days of life. The potential benefit of a higher median oxygen saturation on survival must be balanced with the increased risk of morbidities associated with hyperoxia exposure such as retinopathy of prematurity. Intermittent hypoxic episodes are almost universal in extremely low birth weight infants (<1 kg birth weight) and frequently go undocumented by the clinical staff. 18 They are typically a consequence of impaired respiratory control and may occur in spontaneously breathing or ventilated infants born preterm. 3, 19, 20 Intermittent hypoxia and/or related apnea events during early postnatal life have been linked to neurodevelopmental impairment, [21] [22] [23] [24] attention deficit disorder, 25 neurotransmitter imbalance, 25 retinopathy of prematurity, 3, 26 cardiovascular regulation, 27 and growth restriction 27 in both human infants and neonatal animal models. We are only beginning to appreciate that patterns of intermittent hypoxemia may play a role in both detrimental and beneficial effects on the respiratory, cardiovascular, and nervous systems, among others. 26, 28 For example, both human and rodent neonatal models suggest that the clustering of intermittent hypoxemia events can lead to the increased neovascularization associated with severe retinopathy of prematurity. 8, 29 Recent data from COT have shown an association between intermittent hypoxemia events and motor/cognitive impairment, language delay, and severe retinopathy of prematurity that was limited to intermittent hypoxemia events of ≥1 minute in duration. 4 In contrast with COT, our observation between intermittent hypoxemia events and survival in the SGA cohort was not limited to longer intermittent hypoxemia events suggesting that a high incidence of intermittent hypoxemia events of even 20 seconds in duration during early postnatal life may put infants born SGA at risk of death during the first 3 months of life. Owing to the nature of survival analysis and the high dropout rate owing to death during the first week of life, we cannot address the detriments of such events on mortality beyond the first few days of life.
It is well-known that infants born SGA have a lower survival compared with infants born AGA. 30, 31 The greatest proportion of mortality among infants born SGA has been reported to occur during the first 12 hours of life.
30 Inclusion in the current study relied on the presence of ≥3 days of oxygen saturation waveform data and, correspondingly, survival of ≥3 days. Therefore, this study may represent relatively more stable infants in the SGA spectrum. Nevertheless, intrauterine growth restriction has demonstrated lasting effects on lung structure and function, including decreased pulmonary alveolar and vessel growth and pulmonary arterial endothelial cell dysfunction in a sheep model 32 in addition to a predisposition to bronchopulmonary dysplasia 31 and pulmonary hypertension 33 in human neonates. Infants born SGA had a comparable number of intermittent hypoxemia events lasting <1 minutes when compared with infants born AGA (Figure 1 ), yet, in contrast with infants born AGA, survival of infants born SGA was associated highly with the incidence of both long and short intermittent hypoxemia events. Therefore, the risk factors associated with intrauterine growth restriction combined with a future hit of either sustained and/or intermittent hypoxia during a vulnerable transition period during the first few days of life may have provided a lethal interaction, resulting in increased mortality in this fragile infant cohort.
Analyses were not adjusted for potential confounding factors (asphyxia at birth, ventilator treatment, hypoglycemia, etc) because it was unclear which factors were additional contributory factors as opposed to causal as a result of being SGA. We also acknowledge that many comparisons were performed thus inflating the possibility of a type I error. Last, 204 infants were not included in the analysis owing to missing or unacceptable quality of data during the first 3 days of life. Because these cases occurred at random we do not anticipate that this would cause a selection bias between infant groups.
The results of this study suggest that the optimal achieved oxygen saturation during the first few days of life to improve survival in preterm infants, and especially infants born SGA, may be an oxygen saturation of >92%. The application of such a paradigm in clinical practice may be unrealistic given the multitude of studies showing the challenge of keeping infants within any given target, regardless of the use of manual or automated adjustments in supplemental oxygen. 34, 35 The results of this study may be a reflection of the move toward oxygen saturation monitoring and away from transcutaneous PO2 monitoring whereby, even infants in the higher saturation target of 90%-95% often have PaO2 levels well below the recommended published guidelines. 36 In summary, this study found that infants born SGA in the lower target group had the lowest median oxygen saturation and highest incidence of longer intermittent hypoxemia during the first 3 days of life compared with infants born AGA with a lower target and both infants born SGA with a higher target and infants born AGA with a higher target. In addition, this study found an association between median oxygen saturation during the first 3 days of life and infant survival at 90 days in both infants born AGA and infants born SGA. In contrast, the association between time with hypoxemia and incidence of intermittent hypoxemia events with decreased survival was limited to the infants born SGA. Therefore, maintaining extremely low gestational age infants, and especially infants born SGA, at the higher end of recommended guidelines during the first few days of life may improve infant survival. ■
